1. Baird AE. Genetics and genomics of stroke: novel approaches. J Am Coll Cardiol. 56:245–253. 2010.
2. Cao Q, Rong S, Repa JJ, Clair RS, Parks JS, Mishra N. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb Vasc Biol. 34:1871–1879. 2014.

3. Chinese Society of Neurology. The diagnosis of cerebrovascular diseases. CHN of J Neurol. 29:379–380. 1996.
4. Ferronato S, Mombello A, Posenato I, Candiani P, Scuro A, Setacci C, et al. Expression of circulating miR-17-92 cluster and HDAC9 gene in atherosclerotic patients with unstable and stable carotid plaques. Genet Test Mol Biomarkers. 21:402–405. 2017.

5. Han X, Han X, Wang Z, Shen J, Dong Q. HDAC9 regulates ox-LDLinduced endothelial cell apoptosis by participating in inflammatory reactions. Front Biosci (Landmark Ed). 21:907–917. 2016.

6. Han Y, Sun W, Wang L, Tao S, Tian L, Hao Y, et al. HDAC9 gene is associated with stroke risk in a Chinese population. Exp Biol Med (Maywood). 238:842–847. 2013.

7. He M. The role and mechanism of acetylation epigenetic regulation molecule HDAC4/5 in ischemic brain injury. Jinan: Shandong University;2012.
8. International Stroke Genetics Consortium (ISGC); Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 44:328–333. 2012.
9. Kalkonde YV, Sahane V, Deshmukh MD, Nila S, Mandava P, Bang A. High prevalence of stroke in Rural Gadchiroli, India: a community-based Study. Neuroepidemiology. 46:235–239. 2016.

10. Kaluza D, Kroll J, Gesierich S, Manavski Y, Boeckel JN, Doebele C, et al. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells. Arterioscler Thromb Vasc Biol. 33:533–543. 2013.

11. Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A. 104:17335–17340. 2007.

12. Liu WL, Lin YJ, Tao J, Peng J, Li GP, Chen LD, et al. Study on the correlation between HDAC9 gene SNPs and large vessel atherosclerosisinduced ischemic stroke. Chin J Stroke. 11:269–276. 2016.
13. Lu S, Li H, Li K, Fan XD. HDAC9 promotes brain ischemic injury by provoking lκBα/NF-κB and MAPKs signaling pathways. Biochem Biophys Res Commun. 503:1322–1329. 2018.

14. Markus HS, Mäkelä KM, Bevan S, Raitoharju E, Oksala N, Bis JC, et al. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke. 44:1220–1225. 2013.

15. Musunuru K, Hickey KT, Al-Khatib SM, Delles C, Fornage M, Fox CS, et al. Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. Circ Cardiovasc Genet. 8:216–242. 2015.

16. Petrie K, Guidez F, Howell L, Healy L, Waxman S, Greaves M, et al. The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem. 278:16059–16072. 2003.

17. Prestel M, Prell-Schicker C, Webb T, Malik R, Lindner B, Ziesch N, et al. The atherosclerosis risk variant rs2107595 mediates allele-specific transcriptional regulation of HDAC9 via E2F3 and Rb1. Stroke. 50:2651–2660. 2019.

18. Qingxu G, Yan Z, Jiannan X, Yunlong L. Association between the gene polymorphisms of HDAC9 and the risk of atherosclerosis and ischemic stroke. Pathol Oncol Res. 22:103–107. 2016.

19. Qingxu G, Yan Z, Jiannan X, Yunlong L. Association between the gene polymorphisms of HDAC9 and the risk of atherosclerosis and ischemic stroke. Pathol Oncol Res. 22:103–107. 2016.

20. Smith JD. New role for histone deacetylase 9 in atherosclerosis and inflammation. Arterioscler Thromb Vasc Biol. 34:1798–1799. 2014.

21. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 11:951–962. 2012.

22. Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in South, East, and South-East Asia: a review. J Stroke. 19:286–294. 2017.

23. Wang M, Gu M, Li Z, Sun B, Cheng X, Dai Z, et al. HDAC9 polymorphisms predict susceptibility, severity, and short-term outcome of large artery atherosclerotic stroke in Chinese population. J Mol Neurosci. 67:165–171. 2019.

24. Wang X, Sun Z, Zhang Y, Tian X, Li Q, Luo J. Impact of the PDE4D gene polymorphism and additional SNP-SNP and gene-smoking interaction on ischemic stroke risk in Chinese Han population. Neurol Res. 39:351–356. 2017.

25. Wang XB, Han YD, Sabina S, Cui NH, Zhang S, Liu ZJ, et al. HDAC9 variant Rs2107595 modifies susceptibility to coronary artery disease and the severity of coronary atherosclerosis in a Chinese Han population. PLoS One. 11:e0160449. 2016.

26. Xu YL, Hu YY, Li JW, Zhou L, Li L, Niu YM. Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis. Neuropsychiatr Dis Treat. 15:1015–1029. 2019.
27. Yeo BPH, Foong LC, Tam SM, Lee V, Hwang SS. Gene isolation using degenerate primers targeting protein motif: a laboratory exercise. Biochem Mol Biol Educ. 46:47–53. 2018.

28. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 387:251–272. 2016.

29. Zhu QB, Wu GM, Li GM, et al. Study on the relationship between single nucleotides polymorphism rs2240419 of HDAC9 gene and the susceptibility to ischemic stroke and TCM syndromes in Guangdong Han population. Chinese Journal for Clinicians. 47:35–40. 2019.
30. Zhu R, Liu X, He Z, Li Q. MiR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population. Neurochem Res. 39:1709–1716. 2014.
